These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26316152)

  • 21. Analogs of 1alpha,25-dihydroxyvitamin D3 with high potency in induction of osteoclastogenesis and prevention of dendritic cell differentiation: synthesis and biological evaluation of 2-substituted 19-norvitamin D analogs.
    Shimazaki M; Miyamoto Y; Yamamoto K; Yamada S; Takami M; Shinki T; Udagawa N; Shimizu M
    Bioorg Med Chem; 2006 Jul; 14(13):4645-56. PubMed ID: 16513359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation, and crystal structure.
    Shimizu M; Miyamoto Y; Takaku H; Matsuo M; Nakabayashi M; Masuno H; Udagawa N; DeLuca HF; Ikura T; Ito N
    Bioorg Med Chem; 2008 Jul; 16(14):6949-64. PubMed ID: 18539034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for the activation of 1alpha-hydroxyvitamin D2 by 25-hydroxyvitamin D-24-hydroxylase: delineation of pathways involving 1alpha,24-dihydroxyvitamin D2 and 1alpha,25-dihydroxyvitamin D2.
    Masuda S; Strugnell SA; Knutson JC; St-Arnaud R; Jones G
    Biochim Biophys Acta; 2006 Feb; 1761(2):221-34. PubMed ID: 16516540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel 2-alkyl-1alpha,25-dihydroxy-19-norvitamin D3: efficient synthesis with Julia olefination, evaluation of biological activity and development of new analyzing system for co-activator recruitment.
    Arai MA; Kittaka A
    Anticancer Res; 2006; 26(4A):2621-31. PubMed ID: 16886672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and antiproliferative activity of side-chain unsaturated and homologated analogs of 1,25-dihydroxyvitamin D(2). (24E)-(1S)-24-Dehydro-24a-homo-1,25-dihydroxyergocalciferol and congeners.
    Chodyński M; Wietrzyk J; Marcinkowska E; Opolski A; Szelejewski W; Kutner A
    Steroids; 2002 Aug; 67(9):789-98. PubMed ID: 12123791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of receptor binding, biological activity, and in vivo tracer kinetics for 1,25-dihydroxyvitamin D3, 1,25-dihydroxyvitamin D2, and its 24 epimer.
    Reinhardt TA; Ramberg CF; Horst RL
    Arch Biochem Biophys; 1989 Aug; 273(1):64-71. PubMed ID: 2547343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The antagonism between 2-methyl-1,25-dihydroxyvitamin D3 and 2-methyl-20-epi-1,25-dihydroxyvitamin D3 in non-genomic pathway-mediated biological responses induced by 1alpha,25-dihydroxyvitamin D3 assessed by NB4 cell differentiation.
    Miura D; Norman AW; Mizwicki MT; Fujishima T; Konno K; Kittaka A; Takayama H; Ishizuka S
    J Steroid Biochem Mol Biol; 2005 Apr; 94(5):469-79. PubMed ID: 15876412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1 alpha,25-dihydroxyvitamin D3 analogs featuring aromatic and heteroaromatic rings: design, synthesis, and preliminary biological testing.
    Posner GH; Li Z; White MC; Vinader V; Takeuchi K; Guggino SE; Dolan P; Kensler TW
    J Med Chem; 1995 Oct; 38(22):4529-37. PubMed ID: 7473581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and metabolic studies of 1α,2α,25-, 1α,4α,25- and 1α,4β,25-trihydroxyvitamin D3.
    Takano M; Sawada D; Yasuda K; Nishikawa M; Takeuchi A; Takagi K; Horie K; Reddy GS; Chen TC; Sakaki T; Kittaka A
    J Steroid Biochem Mol Biol; 2015 Apr; 148():34-7. PubMed ID: 25263656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and structure-activity relationships of 16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs having side chains of different sizes.
    Takaku H; Miyamoto Y; Asami S; Shimazaki M; Yamada S; Yamamoto K; Udagawa N; DeLuca HF; Shimizu M
    Bioorg Med Chem; 2008 Feb; 16(4):1796-815. PubMed ID: 18032055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Highly active analogs of 1alpha,25-dihydroxyvitamin D(3) that resist metabolism through C-24 oxidation and C-3 epimerization pathways.
    Uskokovic MR; Norman AW; Manchand PS; Studzinski GP; Campbell MJ; Koeffler HP; Takeuchi A; Siu-Caldera ML; Rao DS; Reddy GS
    Steroids; 2001; 66(3-5):463-71. PubMed ID: 11179755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Highly potent 2-methylene analogs of 1α,25-dihydroxyvitamin D3: synthesis and biological evaluation.
    Sibilska IK; Szybinski M; Sicinski RR; Plum LA; Deluca HF
    J Steroid Biochem Mol Biol; 2013 Jul; 136():9-13. PubMed ID: 23410597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and biological activity of a 1 alpha,25-dihydroxyvitamin D2 analog bearing an amide group in the side-chain.
    Konno K; Ojima K; Hayashi T; Tanabe M; Takayama H
    Chem Pharm Bull (Tokyo); 1997 Jan; 45(1):185-8. PubMed ID: 9023979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent results on A-ring modification of 1alpha,25-dihydroxyvitamin D3: design and synthesis of VDR-agonists and antagonists with high biological activity.
    Saito N; Honzawa S; Kittaka A
    Curr Top Med Chem; 2006; 6(12):1273-88. PubMed ID: 16848741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor properties of (5E,7E) analogs of vitamin D3.
    Filip B; Milczarek M; Wietrzyk J; Chodyński M; Kutner A
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):399-402. PubMed ID: 20227499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New C15-substituted active vitamin D3.
    Shindo K; Kumagai G; Takano M; Sawada D; Saito N; Saito H; Kakuda S; Takagi K; Ochiai E; Horie K; Takimoto-Kamimura M; Ishizuka S; Takenouchi K; Kittaka A
    Org Lett; 2011 Jun; 13(11):2852-5. PubMed ID: 21539305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular evaluation of vitamin D3 receptor agonists designed for topical treatment of skin diseases.
    Bury Y; Ruf D; Hansen CM; Kissmeyer AM; Binderup L; Carlberg C
    J Invest Dermatol; 2001 May; 116(5):785-92. PubMed ID: 11348471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-calcemic, highly antiproliferative, 1-difluoromethyl hybrid analogs of the natural hormone 1alpha,25-dihydroxyvitamin D3: design, synthesis, and preliminary biological evaluation.
    Peleg S; Petersen KS; Suh BC; Dolan P; Agoston ES; Kensler TW; Posner GH
    J Med Chem; 2006 Dec; 49(25):7513-7. PubMed ID: 17149880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Removal of C-ring from the CD-ring skeleton of 1alpha,25-dihydroxyvitamin D3 does not alter its target tissue metabolism significantly.
    Reddy GS; Robinson M; Wang G; Palmore GT; Gennaro L; Vouros P; De Clercq P; Vandewalle M; Young W; Ling S; Verstuyf A; Bouillon R
    Arch Biochem Biophys; 2007 Apr; 460(2):254-61. PubMed ID: 17196157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor.
    Harant H; Spinner D; Reddy GS; Lindley IJ
    J Cell Biochem; 2000 Apr; 78(1):112-20. PubMed ID: 10797570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.